Author/Creator: Iida, Satofumi - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Iida, Satofumi

1. A comprehensive review of the pharmacokinetics of approved therapeutic monoclonal antibodies in Japan: Are Japanese phase I studies still needed?. (10th January 2014)

Authors:: Chiba, Koji; Yoshitsugu, Hiroyuki; Kyosaka, Yuto; Iida, Satofumi; Yoneyama, Koichiro; Tanigawa, Takahiko; Fukushima, Takashi; Hiraoka, Masaki
Journal:: Journal of clinical pharmacology
Issue:: Volume 54:Number 5(2014:May)
Page Start:: 483
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic‐Pharmacodynamic Modeling and Simulation. (13th July 2017)

Authors:: Saito, Tomohisa; Iida, Satofumi; Terao, Kimio; Kumagai, Yuji
Journal:: Journal of clinical pharmacology
Issue:: Volume 57:Number 12(2017)
Page Start:: 1564
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Population pharmacokinetic–pharmacodynamic modelling and simulation of neutropenia induced by TP300, a novel topoisomerase I inhibitor. (23rd May 2013)

Authors:: Saito, Tomohisa; Iida, Satofumi; Abe, Masaichi; Jones, Keith; Kawanishi, Takehiko; Twelves, Chris
Journal:: Journal of pharmacy and pharmacology
Issue:: Volume 65:Number 8(2013:Aug.)
Page Start:: 1168
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Risk of CYP2C9 induction analyzed by a relative factor approach with human hepatocytes. Issue 5 (October 2019)

Authors:: Endo-Tsukude, Chihiro; Kato, Motohiro; Kaneko, Akihisa; Iida, Satofumi; Kuramoto, Shino; Ishigai, Masaki; Hamada, Akinobu
Journal:: Drug metabolism and pharmacokinetics
Issue:: Volume 34:Issue 5(2019)
Page Start:: 325
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Time‐to‐event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma. (9th March 2018)

Authors:: Nakamura, Mikiko; Xu, Chao; Diack, Cheikh; Ohishi, Norihisa; Lee, Ruey‐min; Iida, Satofumi; Kawanishi, Takehiko; Ohtomo, Toshihiko; Abou‐Alfa, Ghassan K.; Chen, Ya‐Chi
Journal:: British journal of clinical pharmacology
Issue:: Volume 84:Number 5(2018:Nov.)
Page Start:: 944
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗